Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
NUVB
NUVB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NUVB News
Investigation into Nuvation Bio Executives for Breach of Fiduciary Duties
4d ago
PRnewswire
Investigation into Nuvation Bio Executives for Fiduciary Breach
4d ago
Newsfilter
Nuvation Bio Under Investigation for Potential Claims
6d ago
Globenewswire
Knoll Capital Increases Stake in Nuvation Bio by 473,591 Shares
6d ago
Fool
NUVB Stock 52-Week High and Low Analysis
Mar 03 2026
NASDAQ.COM
Nuvation Bio Reports Strong 2025 Financial Results Driven by Lung Cancer Therapy
Mar 03 2026
NASDAQ.COM
Ouster Inc Reports Strong Q4 Results, Shares Surge
Mar 03 2026
Benzinga
Nuvation Bio Inc. Reports Strong Q4 2025 Earnings and Growth Prospects
Mar 03 2026
seekingalpha
Nuvation Bio (NUVB) Q4 2025 Earnings Transcript
Mar 03 2026
NASDAQ.COM
Nuvation Bio Reports Q4 2025 Earnings Highlights
Mar 03 2026
Yahoo Finance
Nuvation Biopress Reports Q4 Earnings with Significant Revenue Growth
Mar 02 2026
seekingalpha
Nuvation Bio Expands SIGMA Study to Phase 3 Trial
Feb 27 2026
Yahoo Finance
Oncolytics Biotech Receives FDA Fast Track Designation for Cancer Treatment
Feb 17 2026
PRnewswire
Oncolytics Biotech Receives FDA Fast Track Designation for Cancer Treatment
Feb 17 2026
PRnewswire
Oncolytics Biotech Receives FDA Fast Track Designation for Pelareorep
Feb 17 2026
Newsfilter
Nuvation Bio (NUVB) Shares Hit Oversold Territory with RSI at 29.5
Jan 12 2026
NASDAQ.COM
Show More News
